WST logo

West Pharmaceutical Services Inc. (WST)

$417.80

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on WST

Market cap

$29.10B

EPS

8.91

P/E ratio

46.8

Price to sales

7.74

Dividend yield

0.249%

Beta

1.134087

Price on WST

Previous close

$416.42

Today's open

$417.03

Day's range

$415.08 - $420.66

52 week range

$223.83 - $438.27

Profile about WST

CEO

Eric M. Green

Employees

10800

Headquarters

Exton, PA

Exchange

New York Stock Exchange

Shares outstanding

69661036

Issue type

Common Stock

WST industries and sectors

Healthcare

Biotechnology & Life Sciences

News on WST

Top 50 High-Quality Dividend Growth Stocks For November 2026

I track 50 high-quality dividend growth stocks to identify favorable entry points, prioritizing long-term total return alongside a growing dividend stream. Forty stocks offer estimated future returns of at least 10%; 27 appear undervalued relative to historical free cash flow. ResMed leads with 41.60% estimated return potential; MarketAxess rose to fifth at 28.50% after a valuation upgrade and higher fair value estimate.

news source

Seeking Alpha • Nov 14, 2026

news preview

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

news source

Seeking Alpha • Nov 13, 2026

news preview

69 Dividend Champions Ranked By Quality Scores (November 2026)

I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued. Forty-nine have quality scores ≥ 7.0, indicating high quality. Top candidates by style: BRO and BMI for growth; BRO, BMI, and RGLD (below $262) for total return; CTBI for income; CAT for past performance.

news source

Seeking Alpha • Nov 7, 2026

news preview

West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Nov 5, 2026

news preview

West to Participate in Upcoming Investor Conference

EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London, UK.

news source

PRNewsWire • Nov 4, 2026

news preview

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

West Pharmaceutical Services NYSE: WST reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics. The company raised its full-year revenue and adjusted earnings outlook following the quarter.

news source

MarketBeat • Oct 31, 2026

news preview

West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript

West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Oct 29, 2026

news preview

West Reports Third-Quarter 2026 Results

Raising Full-Year Net Sales and Adjusted-Diluted EPS guidance EXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the third quarter of 2026.

news source

PRNewsWire • Oct 29, 2026

news preview

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.96 per share a year ago.

news source

Zacks Investment Research • Oct 29, 2026

news preview

Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

news source

Zacks Investment Research • Oct 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in West Pharmaceutical Services Inc.

Open an M1 investment account to buy and sell West Pharmaceutical Services Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in WST on M1